Sine Scleroderma, Limited Cutaneous and Diffused Cutaneous Systemic Sclerosis Survival and Predictors of Mortality
S. De Almeida Chaves(Centre Hospitalier Universitaire de Toulouse), G. Pugnet(Hôpital Rangueil), Mickael Mounié(Inserm), D. Adoué, Laurent Alric, L. Sailler(Université Fédérale de Toulouse Midi-Pyrénées), Martin Michaud(Centre Hospitalier Universitaire de Toulouse), Olivier Lairez(Hôpital Rangueil), L. Astudillo(Hôpital Purpan), Grégoire Prévôt(Hôpital Larrey), David Ribes(Centre Hospitalier Universitaire de Toulouse), T. Porel, Antoine Huart, F. Gaches
Cited by 6
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Proinflammatory Cytokines, Aging, and Age-Related Diseases
|Journal of the American Medical Directors Association|2013|1.1k
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
|Journal of the American Society of Nephrology|2010|470